692 related articles for article (PubMed ID: 25365529)
21. Future prospects for the chemotherapy of human trypanosomiasis. 1. Novel approaches to the chemotherapy of trypanosomiasis.
Fairlamb AH
Trans R Soc Trop Med Hyg; 1990; 84(5):613-7. PubMed ID: 2278053
[TBL] [Abstract][Full Text] [Related]
22. The chemotherapy of protozoal infections: whither?
Steck EA
J Protozool; 1981 Feb; 28(1):30-5. PubMed ID: 6265632
[No Abstract] [Full Text] [Related]
23. Hybrid Molecules: Promising Compounds for the Development of New Treatments Against Leishmaniasis and Chagas Disease.
Cardona-G W; Yepes AF; Herrera-R A
Curr Med Chem; 2018; 25(30):3637-3679. PubMed ID: 29521209
[TBL] [Abstract][Full Text] [Related]
24. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
[TBL] [Abstract][Full Text] [Related]
25. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
[TBL] [Abstract][Full Text] [Related]
26. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
[TBL] [Abstract][Full Text] [Related]
27. Pentamidine dosage: a base/salt confusion.
Dorlo TP; Kager PA
PLoS Negl Trop Dis; 2008 May; 2(5):e225. PubMed ID: 18509543
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and Evaluation of Biological Activities of Bis(spiropyrazolone)cyclopropanes: A Potential Application against Leishmaniasis.
Barreiro-Costa O; Morales-Noboa G; Rojas-Silva P; Lara-Barba E; Santamaría-Aguirre J; Bailón-Moscoso N; Romero-Benavides JC; Herrera A; Cueva C; Ron-Garrido L; Poveda A; Heredia-Moya J
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443548
[TBL] [Abstract][Full Text] [Related]
29. Drugs for parasitic infections.
Med Lett Drugs Ther; 1986 Jan; 28(706):9-16. PubMed ID: 3945225
[No Abstract] [Full Text] [Related]
30. The pharmacology of leishmaniasis.
Balaña-Fouce R; Reguera RM; Cubría JC; Ordóñez D
Gen Pharmacol; 1998 Apr; 30(4):435-43. PubMed ID: 9580315
[TBL] [Abstract][Full Text] [Related]
31. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
Orosco D; Mendoza AR; Meléndez CM
Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
[TBL] [Abstract][Full Text] [Related]
32. Therapeutics against Trypanosomiasis.
Manuja A; Kumar B
Curr Top Med Chem; 2018; 18(25):2138-2140. PubMed ID: 30698105
[No Abstract] [Full Text] [Related]
33. Parasitology. Drugs to combat tropical protozoan parasites.
Gelb MH; Hol WG
Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
[No Abstract] [Full Text] [Related]
34. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
Orenes Lorente S; Gómez R; Jiménez C; Cammerer S; Yardley V; de Luca-Fradley K; Croft SL; Ruiz Perez LM; Urbina J; Gonzalez Pacanowska D; Gilbert IH
Bioorg Med Chem; 2005 May; 13(10):3519-29. PubMed ID: 15848765
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.
Suryawanshi SN; Chandra N; Kumar P; Porwal J; Gupta S
Eur J Med Chem; 2008 Nov; 43(11):2473-8. PubMed ID: 18243420
[TBL] [Abstract][Full Text] [Related]
36. Biological evaluation of glycosyl-isoindigo derivatives against the pathogenic agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis).
Bouchikhi F; Anizon F; Brun R; Moreau P
Bioorg Med Chem Lett; 2011 Nov; 21(21):6319-21. PubMed ID: 21937228
[TBL] [Abstract][Full Text] [Related]
37. Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.
Espuelas S; Plano D; Nguewa P; Font M; Palop JA; Irache JM; Sanmartín C
Curr Med Chem; 2012; 19(25):4259-88. PubMed ID: 22834813
[TBL] [Abstract][Full Text] [Related]
38. Development of miltefosine for the leishmaniases.
Berman JD
Mini Rev Med Chem; 2006 Feb; 6(2):145-51. PubMed ID: 16472183
[TBL] [Abstract][Full Text] [Related]
39. Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets.
Das A; Dasgupta A; Sengupta T; Majumder HK
Trends Parasitol; 2004 Aug; 20(8):381-7. PubMed ID: 15246322
[TBL] [Abstract][Full Text] [Related]
40. New strategies and paradigm for drug target discovery: a special focus on infectious diseases tuberculosis, malaria, leishmaniasis, trypanosomiasis and gastritis.
Neelapu NR; Srimath-Tirumala-Peddinti RC; Nammi D; Pasupuleti AC
Infect Disord Drug Targets; 2013 Oct; 13(5):352-64. PubMed ID: 24712675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
